Wuhan General Gr Stock Working Capital
| WUHNDelisted Stock | USD 0.0004 0.00 0.00% |
Wuhan General Gr fundamentals help investors to digest information that contributes to Wuhan General's financial success or failures. It also enables traders to predict the movement of Wuhan Pink Sheet. The fundamental analysis module provides a way to measure Wuhan General's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Wuhan General pink sheet.
Wuhan |
Wuhan General Gr Company Working Capital Analysis
Wuhan General's Working Capital is a measure of company efficiency and operating liquidity. The working capital is usually calculated by subtracting Current Liabilities from Current Assets. It is an important indicator of the firm ability to continue its normal operations without additional debt obligations. .
More About Working Capital | All Equity Analysis
Working Capital | = | Current Assets | - | Current Liabilities |
Current Wuhan General Working Capital | 18 M |
Most of Wuhan General's fundamental indicators, such as Working Capital, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Wuhan General Gr is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Working Capital can be positive or negative, depending on how much of current debt the company is carrying on its balance sheet. In general terms, companies that have a lot of working capital will experience more growth in the near future since they can expand and improve their operations using existing resources. On the other hand, companies with small or negative working capital may lack the funds necessary for growth or future operation. Working Capital also shows if the company has sufficient liquid resources to satisfy short-term liabilities and operational expenses.
CompetitionAs per the company's disclosures, Wuhan General Gr has a Working Capital of 18 M. This is 95.77% lower than that of the Pharmaceuticals sector and significantly higher than that of the Health Care industry. The working capital for all United States stocks is 98.78% higher than that of the company.
Wuhan Working Capital Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Wuhan General's direct or indirect competition against its Working Capital to detect undervalued stocks with similar characteristics or determine the pink sheets which would be a good addition to a portfolio. Peer analysis of Wuhan General could also be used in its relative valuation, which is a method of valuing Wuhan General by comparing valuation metrics of similar companies.Wuhan General is currently under evaluation in working capital category among its peers.
Wuhan Fundamentals
| Return On Equity | -0.0878 | ||||
| Return On Asset | -0.005 | ||||
| Profit Margin | (0.13) % | ||||
| Operating Margin | (0.03) % | ||||
| Current Valuation | 3.05 M | ||||
| Shares Outstanding | 33.93 M | ||||
| Number Of Shares Shorted | 12.62 K | ||||
| Price To Earning | (0.06) X | ||||
| Price To Book | 0.04 X | ||||
| Price To Sales | 0.05 X | ||||
| Revenue | 80.38 M | ||||
| Gross Profit | 14.54 M | ||||
| EBITDA | 379.92 K | ||||
| Net Income | (10.59 M) | ||||
| Cash And Equivalents | 18.79 M | ||||
| Cash Per Share | 0.55 X | ||||
| Total Debt | 118.8 M | ||||
| Debt To Equity | 1.11 % | ||||
| Current Ratio | 1.10 X | ||||
| Book Value Per Share | 2.34 X | ||||
| Cash Flow From Operations | (21.86 M) | ||||
| Short Ratio | 0.15 X | ||||
| Earnings Per Share | (0.35) X | ||||
| Number Of Employees | 700 | ||||
| Beta | 1.94 | ||||
| Market Capitalization | 3.05 M | ||||
| Total Asset | 286.58 M | ||||
| Retained Earnings | 15 M | ||||
| Working Capital | 18 M | ||||
| Current Asset | 197 M | ||||
| Current Liabilities | 179 M | ||||
| Net Asset | 286.58 M |
About Wuhan General Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Wuhan General Gr's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Wuhan General using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Wuhan General Gr based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Pair Trading with Wuhan General
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Wuhan General position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Wuhan General will appreciate offsetting losses from the drop in the long position's value.Moving together with Wuhan Pink Sheet
Moving against Wuhan Pink Sheet
| 0.8 | YCBD-PA | cbdMD Inc | PairCorr |
| 0.75 | HROWM | Harrow Health, 11875 | PairCorr |
| 0.72 | INIS | International Isotopes | PairCorr |
| 0.58 | PETQ | PetIQ Inc | PairCorr |
| 0.54 | ELTP | Elite Pharma | PairCorr |
The ability to find closely correlated positions to Wuhan General could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Wuhan General when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Wuhan General - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Wuhan General Gr to buy it.
The correlation of Wuhan General is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Wuhan General moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Wuhan General Gr moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Wuhan General can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out Your Current Watchlist to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in rate. You can also try the Premium Stories module to follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope.
Other Consideration for investing in Wuhan Pink Sheet
If you are still planning to invest in Wuhan General Gr check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Wuhan General's history and understand the potential risks before investing.
| Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
| Share Portfolio Track or share privately all of your investments from the convenience of any device | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance |